Tasquinimod Is an Allosteric Modulator of HDAC4 Survival Signaling within the Compromised Cancer MicroenvironmentJohn T. Isaacs, Tomas Leanderson, Susan L. Dalrymple et al.|Cancer Research|2012Cited by 113
Characterization of structural, biochemical, pharmacokinetic, and pharmacodynamic properties of the LSD1 inhibitor bomedemstat in preclinical modelsSumer Jasmine, W. Nathaniel Brennen|The Prostate|2024Cited by 10